Related Experiment Video
Updated: May 7, 2026
12:19
Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
Published on: June 7, 2024
A personalized view on cancer immunotherapy.
Laura Wayteck1, Karine Breckpot2, Jo Demeester1
1Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, 9000 Ghent, Belgium.
Cancer Letters
|September 21, 2013
Summary
Personalized cancer immunotherapy, including tumor-specific antigen identification for vaccines and T cell therapies, improves treatment efficacy. Predictive biomarker screening is crucial for combination cancer immunotherapies.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer immunotherapy has shown promise, achieving complete responses in some patients resistant to standard treatments.
- Tumor heterogeneity and individual immune variations limit the effectiveness of current immunotherapies, benefiting only specific patient subsets.
Purpose of the Study:
- To review personalized approaches for enhancing cancer immunotherapy efficacy and minimizing adverse effects.
- To emphasize the role of tumor-specific antigens in developing personalized cancer vaccines and adoptive T cell therapies.
Main Methods:
- Literature review focusing on personalized cancer immunotherapy strategies.
- Analysis of advances in combination cancer (immuno-)therapies.
- Discussion on the importance of patient-specific predictive biomarker screening.
Main Results:
- Personalized strategies, such as identifying tumor-specific antigens, can improve treatment outcomes.
- Combination immunotherapies show promising clinical results.
- Patient-specific biomarker screening is essential for treatment selection.
Conclusions:
- A personalized approach, incorporating tumor-specific antigens and predictive biomarkers, is key to optimizing cancer immunotherapy.
- Tailoring treatments to individual patients enhances efficacy and reduces side effects in cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...